ESR1 and breast carcinoma: In addition, manipulation of lipid rafts in effector cells by secreted SM may also explain the selective killing of TNBC, but not ER+ or normal breast epithelial cells, as breast cancer cells with different receptor status have been found to have different lipid raft compositions30, and so, might respond differently to secreted SM.